Results 31 to 40 of about 306,089 (345)

Bismuth-based quadruple therapy following H. Pylori eradication failures: A multicenter study in clinical practice [PDF]

open access: yes, 2015
Background & Aims: Helicobacter pylori (H. pylori) eradication in patients who failed one or more therapeutic attempts remains challenging. This study aimed to assess the efficacy of three-in-one capsules bismuth-based quadruple therapy (Pylera®) in ...
Zullo, Angelo   +16 more
core   +8 more sources

Helicobacter pylori and Extragastric Diseases – Other Helicobacters [PDF]

open access: yesHelicobacter, 2005
ABSTRACTThe involvement of Helicobacter pylori in the pathogenesis of extragastric diseases continues to be an interesting topic in the field of Helicobacter‐related pathology.Although conflicting findings have been reported for most of the disorders, a role of H.
Nilsson, Ho   +5 more
openaire   +11 more sources

Identification of campylobacter species isolates with phenotypic methods and polymerase chain reaction [PDF]

open access: yesSrpski Arhiv za Celokupno Lekarstvo, 2014
Introduction. Campylobacter jejuni (C. jejuni) and Campylobacter coli (C. coli) are the most common bacterial causes of enterocolitis in humans. However, identification of the species level is not always possible using standard biochemical tests.
Miljković-Selimović Biljana   +4 more
doaj   +1 more source

Comparison of omeprazole, metronidazole and clarithromycin with omeprazole/amoxicillin dual-therapy for the cure of Helicobacter pylori infection [PDF]

open access: yes, 1998
In this randomized, multicenter trial, we evaluated the effectiveness and side effect profile of a modified omeprazole-based triple therapy to cure Helicobacter pylori infection.
Bayerdörffer, Ekkehard   +11 more
core   +1 more source

c‐Rel–dependent Chk2 signaling regulates the DNA damage response limiting hepatocarcinogenesis

open access: yesHepatology, EarlyView., 2022
In response to genotoxic injury, c‐Rel upregulates ATM‐Chk2‐p53 pathway DNA damage proteins to limiting hepatocarcinogenesis. Abstract Background and Aims Hepatocellular carcinoma (HCC) is a leading cause of cancer‐related death. The NF‐κB transcription factor family subunit c‐Rel is typically protumorigenic; however, it has recently been reported as a
Jack Leslie   +17 more
wiley   +1 more source

Riboregulation in the Major Gastric Pathogen Helicobacter pylori

open access: yesFrontiers in Microbiology, 2021
Helicobacter pylori is a Gram-negative bacterial pathogen that colonizes the stomach of about half of the human population worldwide. Infection by H.
Alejandro Tejada-Arranz   +2 more
doaj   +1 more source

Epidemiology of Helicobacter pylori infection in dyspeptic Ghanaian patients

open access: yesThe Pan African Medical Journal, 2015
INTRODUCTION: Helicobacter pylori is a gram-negative urease-producing bacteriumcausally linked with gastritis, peptic ulcer disease and gastric adenocarcinoma.
Timothy Nii Akushe Archampong   +5 more
doaj   +1 more source

Association of Helicobacter pylori vacA polymorphisms with the risk of gastric precancerous lesions in a Moroccan population

open access: yesJournal of Infection in Developing Countries, 2021
Introduction: Helicobacter pylori infection is the major risk factor of atrophic gastritis and intestinal metaplasia. The vacA gene is one of the most virulence factors of H.
Mohamed Reda Jouimyi   +9 more
doaj   +1 more source

Low Helicobacter pylori eradication rates with 4- and 7-day regimens in an Iranian population [PDF]

open access: yes
Background: In Iran, there is insufficient information on the efficacy of Helicobacter pylori eradication regimens shorter than 10 days. This study aims at assessing the efficacy of 4- and 7-day H. pylori eradication regimens in a high-incidence area of
بابایی, مسعود   +15 more
core   +1 more source

Formulation and evaluation of floating mucoadhesive alginate beads for targetingHelicobacter pylori [PDF]

open access: yes, 2015
Objectives: There are various obstacles in the eradication of Helicobacter.pylori (H. pylori) infections, including low antibiotic levels and poor accessibility of the drug at the site of the infection.
Adebisi   +59 more
core   +1 more source

Home - About - Disclaimer - Privacy